Medicare Enrolled
Dr. Ezra Mirvish, M.D.
Dermatology · Monroeville, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mirvish from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mirvish?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mirvish
Dr. Ezra Mirvish is a dermatology specialist in Monroeville, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Mirvish performed 5,482 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mirvish received a total of $7,681 from 39 pharmaceutical and/or device companies across 516 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mirvish is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 15% volume in PA
$7,681 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,482
Medicare services
Top 15% in PA for dermatology
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,240 | $5 | $84 |
| Allergy skin patch test A diagnostic test where small amounts of potential allergens are applied to the skin to identify substances that cause an allergic reaction. |
906 | $4 | $56 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
780 | $57 | $263 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
528 | $36 | $304 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
268 | $76 | $419 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
240 | $57 | $378 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $89 | $372 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $38 | $148 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
74 | $118 | $734 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
68 | $68 | $321 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
62 | $37 | $205 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
42 | $1 | $16 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
35 | $118 | $696 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $100 | $474 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
14 | $76 | $318 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
11 | $55 | $678 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,681
Total received (2018-2024)
Avg $1,097/year across 7 years
Top 21% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
516
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,678
2023
$1,924
2022
$1,420
2021
$521
2020
$259
2019
$1,248
2018
$630
Payments by company (2024)
ABBVIE INC.
$396
E.R. Squibb & Sons, L.L.C.
$364
GENZYME CORPORATION
$197
Janssen Biotech, Inc.
$181
LEO Pharma Inc.
$163
Lilly USA, LLC
$135
Amgen Inc.
$71
Dermavant Sciences, Inc.
$66
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Novartis Pharmaceuticals Corporation
$23
Regeneron Healthcare Solutions, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Top 3 companies account for 57.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,181
Janssen Biotech, Inc.
$1,077
Lilly USA, LLC
$810
E.R. Squibb & Sons, L.L.C.
$554
LEO Pharma Inc.
$459
Amgen Inc.
$449
GENZYME CORPORATION
$448
Novartis Pharmaceuticals Corporation
$426
AbbVie Inc.
$219
Regeneron Healthcare Solutions, Inc.
$216
PFIZER INC.
$213
Sun Pharmaceutical Industries Inc.
$201
PruGen, Inc. Pharmaceuticals
$178
Celgene Corporation
$141
AbbVie, Inc.
$122
Incyte Corporation
$108
Galderma Laboratories, L.P.
$105
Ortho Dermatologics, a division of Bausch Health US, LLC
$99
Dermavant Sciences, Inc.
$81
Almirall LLC
$73
Biofrontera Inc.
$68
Encore Dermatology Inc.
$51
UCB, Inc.
$51
DUSA Pharmaceuticals, Inc.
$46
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Bayer HealthCare Pharmaceuticals Inc.
$38
Blueprint Medicines Corporation
$32
SANOFI-AVENTIS U.S. LLC
$21
Genentech USA, Inc.
$20
Nabriva Therapeutics, plc
$19
TARO PHARMACEUTICALS USA, INC.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
DERMIRA, INC.
$17
Promius Pharma LLC
$17
Arcutis Biotherapeutics, Inc.
$16
VYNE Pharmaceuticals Inc.
$15
Merck Sharp & Dohme Corporation
$14
Aclaris Therapeutics, Inc.
$13
MAYNE PHARMA COMMERCIAL LLC
$7
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Aczone · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BRYHALI · COSENTYX · CYLTEZO · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · EFUDEX · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Halog · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SIVEXTRO · SKYRIZI · SOOLANTRA · Sernivo · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · XOLAIR
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
89
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
FORBES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mirvish is a clinical cardiology specialist, with above-average Medicare volume (top 15% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mirvish experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mirvish performed 2,240 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mirvish receive payments from pharmaceutical companies?
Yes. Dr. Mirvish received a total of $7,681 from 39 companies across 516 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mirvish's costs compare to other dermatologists in Monroeville?
Dr. Mirvish's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mirvish) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Monroeville
Browse dermatologists in Monroeville ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in PA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in PA
Which PA dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology